These findings suggest that activation of both the p-ERK1/2 and PI-3K/AKT signaling pathways might be involved in malignant transformation and progression of gallbladder adenocarcinoma. On multivariate analysis, there was a significant association between p-ERK1/2 over-expression and reduced survival

(Table 4). To our knowledge, this is the first Tanespimycin concentration report showing a correlation of p-EKR1/2 and PI3-K expression with clinical and pathological features, including tumor size, lymph node metastasis and surround tissue invasion. Hori et al [11] demonstrated that 77% of extra-hepatic biliary tract cancer showed positive staining for p-MAPK and 47% for p-AKT. However, those results showed no positive correlation between p-MAPK/p-AKT expression and clinical and pathological features, including tumor stage and pT category in extra-hepatic biliary tract cancer. The study performed by Hori et al was based on a small cohort with 30 patients including 15 with gallbldadder cancer, 13 with bile duct cancer MS-275 datasheet and 2 with ampullary cancer. Another study by Wu et al. also revealed elevated level of p-AKT in 74.1% (20 of 27) of human gallbladder cancer specimens [12]. A number of other studies showed similar positive

rates of expression of p-MAPK/p-ERK1/2 or p-AKT in cholangiocarcinoma [7], intra-hepatic cholangiocarcinoma [8], and cholangiocarcinoma [13], but the association with clinical and pathological features remain inconclusive. Javle et al. demonstrated that expression of p-AKT may be associated

with improved survival [13]. However, in another study Schmitz et al. showed that neither p-ERK1/2 nor p-AKT expression had an impact on patients survival in a larger and more homogenous cohort of solely intra-hepatic cholangiocarcinoma [8]. ERK1/2 and PI3-K signaling pathways are associated with cell proliferation, transformation and survival. The exact molecular mechanism GPX6 in which ERK1/2 and/or AKT remains constitutively activated in a variety of human cancers is however not well understood. EGFR activation triggers multiple signaling cascades which include MAPK/ERK1/2 and PI3-K/AKT pathways, resulting in cell proliferation, differentiation, angiognenesis, metastasis, and inhibition of apoptosis [14, 15]. Over-expression of EGFR was found in patients with malignancies of gallbladder, ampullary and common bile duct [16–19]. Somatic mutations of EGFR in the tyrosine kinase domain have been identified in a subgroup of patients with cholangiocarcinoma or gallbladder carcinoma [15]. The mutations lead to sustained activation of signaling and results in cell survival and proliferation. Mutations of oncogenes have also been identified in cholangiocarcinoma. For example, K-Ras and B-Raf mutations were found in 22% and 45% of cholangiocarcinoma, respectively [20].

Luciferase activity was measured by luminometer (Lumat LB970). Luciferase

ABT-263 nmr activity was normalized for β-Galactosidase (pSV-β-Galactosidase Control Vector). Experiments were performed in triplicate. 2.8 Small Interfering RNA (siRNA) The Sequence targeted to the site of c-Myb mRNA (GeneBank Accession No. NM_005375) were designed without off-target effects. The sense and antisense strands of c-Myb siRNAs were 5′-GGACGAACUGAUAAUGCUATT-3′ and 5′-UAGCAUUAU CAGUUCGUCCAG-3′, respectively. For transfection of the HCC cells, c-Myb siRNA or a negative-control mismatch sequence (scramble siRNA) was transfected with LipofectAmine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions. 2.9 Western blot Total protein extraction from cultured cells was used in electrophoresis and western blot. Briefly,

twenty micrograms of total protein were separated by standard SDS-PAGE and then transferred to PVDF membranes. The membranes were washed, blocked, and incubated with the specific primary antihuman antibodies against OPN (1:800) or against c-Myb (1:500), anti-GADPH antibody (1:5000) (Santa Cruz), followed by incubation with horseradish peroxidase-conjugated secondary antibodies. The reactions were detected by enhanced chemiluminescence assay. 2.10 Matrigel invasion assay and migration assay The invasive ability of the transfected cells was determined by the Matrigel (BD Pharmingen) coated 24-well transwell chambers CHIR-99021 ic50 Idoxuridine with upper and lower culture compartments separated by polycarbonate membranes with 8-um pore(Costar, NY, USA). The bottom chamber was filled with DMEM containing 10% FBS as a chemoattractant. The transfected cells (1 ×

105) were seeded on the top chamber and incubated at 37°C with 5% CO2. After 40 hours, the cells removed from the upper surface of the Matrigel by scrubbing with a cotton swab and cells that migrated to the underside of the membrane were stained with Giemsa (Sigma). Five high-power fields were counted and the mean number of cells per field was calculated. The migration assay was similar to the invasion assay only without Matrigel and lasted for 18 hours. The experiments were performed in triplicate. 2.11 Statistical analysis Statistical analyses were performed by the Statistical Package for the Social Sciences version 11.5 (SPSS, Inc., Chicago, IL). Data were expressed as means ± SD, and analyzed using the two-tailed Student’s t-test or the Analysis of Variance (ANOVA). The level of significance was set at P < 0.05. 3. Results 3.1 Differential activity of transcription factors in two HCC cell lines with different OPN expression levels Compared to the weakly tumorigenic and non-metastastic HCC cell line SMMC-7721 cells, HCCLM6 cells with highly metastatic potential expressed high level of OPN (Figure 1A, C). With > 2-fold or < 0.

J Mol Microbiol Biotechnol 2008. 27. Harth G, Maslesa-Galic S, Tullius MV, Horwitz MA: All four Mycobacterium tuberculosis glnA genes encode glutamine synthetase

activities but only GlnA1 is abundantly expressed and essential for bacterial homeostasis. Mol Microbiol 2005, 58:1157–1172.PubMedCrossRef 28. Sarada KV, Rao NA, Venkitasubramanian TA: Isolation and characterisation of glutamate dehydrogenase from Mycobacterium smegmatis CDC 46. Biochim Biophys Acta 1980, 615:299–308.PubMed 29. O’Hare HM, Duran R, Cervenansky C, Bellinzoni M, Wehenkel AM, Pritsch O, Obal G, Baumgartner J, Vialaret J, Johnsson K, Alzari PM: Regulation of glutamate check details metabolism by protein kinases in mycobacteria. Mol Microbiol 2008. 30. Ahmad S, Bhatnagar RK, Venkitasubramanian TA: Changes in the enzyme activities involved in nitrogen assimilation in Mycobacterium smegmatis under various growth conditions. Ann Inst Pasteur Microbiol 1986, 137B:231–237.PubMedCrossRef 31. Camardella L, Di FR, Antignani A, Ciardiello MA, di PG, Coleman JK, Buchan L, Guespin J, Russell NJ: The Antarctic Psychrobacter sp. TAD1 has two cold-active glutamate dehydrogenases with different cofactor specificities. Characterisation of the NAD+-dependent enzyme. Comp Biochem Physiol A Mol Integr Physiol 2002, 131:559–567.PubMedCrossRef 32. Belanger AE, Hatfull GF: Exponential-phase glycogen recycling is essential for GW-572016 order growth of Mycobacterium smegmatis. J Bacteriol

1999, 181:6670–6678.PubMed 33. Villarino A, Duran R, Wehenkel A, Fernandez P, England P, Brodin P, Cole ST, Zimny-Ardnt U, Jungblut PR, Cervenansky C, Alzari PM: Proteomic identification of

M. tuberculosis protein kinase substrates: PknB recruits GarA, a FHA domain-containing protein, through activation loop-mediated Depsipeptide nmr interactions. J Mol Biol 2005, 350:953–963.PubMedCrossRef 34. England P, Wehenkel A, Martins S, Hoos S, Andre-Leroux G, Villarino A, Alzari PM: The FHA-containing protein GarA acts as a phosphorylation-dependent molecular switch in mycobacterial signaling. FEBS Lett 2009, 583:301–307.PubMedCrossRef 35. Niebisch A, Kabus A, Schultz C, Weil B, Bott M: Corynebacterial protein kinase G controls 2-oxoglutarate dehydrogenase activity via the phosphorylation status of the OdhI protein. J Biol Chem 2006, 281:12300–12307.PubMedCrossRef 36. Müller T: Regulation of Glutamate Dehydrogenase in Corynebacterium glutamicum and its impact on nitrogen control. Universiteit zu Köln Mathematisch-Naturwissenschaftlichen Fakultät; 2005. 37. Meers JL, Tempest DW, Brown CM: ‘Glutamine(amide):2-oxoglutarate amino transferase oxido-reductase (NADP); an enzyme involved in the synthesis of glutamate by some bacteria. J Gen Microbiol 1970, 64:187–194.PubMed 38. Brenchley JE, Prival MJ, Magasanik B: Regulation of the synthesis of enzymes responsible for glutamate formation in Klebsiella aerogenes. J Biol Chem 1973, 248:6122–6128.PubMed 39.

monocytogenes. Results and discussion Ruxolitinib nmr Proteomic comparisons between L. monocytogenes mutants expressing only σL, σH, and σC and a quadruple mutant that does not express any alternative σ factors, all grown to stationary phase at 37°C, showed that (i) σH provides, among these three alternative σ factors, positive regulation for the largest number of proteins, consistent with previous transcriptomic studies [7]; (ii) σL appears to contribute

to negative regulation of a number of proteins; (iii) σC regulates a small number of proteins in L. monocytogenes grown to stationary phase at 37°C; and (iv) proteins regulated by multiple alternative σ factors include MptA, which has a potential role in regulation of PrfA. σH positively regulates a large number of proteins and appears to directly and indirectly contribute to transport and metabolism of β-glucosides Our proteomic comparison identified 15 proteins as positively regulated by σH, as supported by higher protein levels (Fold change (FC) ≥ 1.5; p-valuec (p c) < 0.05) in L. monocytogenes ΔBCL as compared to the ΔBCHL strain (Table 1); four of these 15 proteins also showed higher levels in the parent strain (which expresses

all four alternative σ factors) as compared to the quadruple mutant. Overall, positive fold changes for these proteins (in ΔBCL versus ΔBCHL) ranged from 1.55 to 3.39. These 15 proteins represented nine role categories (e.g., “energy metabolism”; learn more “amino acid biosynthesis”; “transport and binding proteins”, see Figure 1); a Monte Carlo simulation of Fisher’s exact test did not find a significant association between positively regulated genes and role categories (p = 0.06); however, individual Fisher’s exact tests did show overrepresentation of proteins in the role category “amino acid biosynthesis” among the 15 proteins that were found to be positively regulated by σH Glycogen branching enzyme (with a significant p-value; p < 0.01; Odds Ratio = 6.26). Some of the 15 proteins positively regulated by σH have likely roles in stress adaptation and

virulence, including Lmo1439 (superoxide dismutase, SodA) [24] and Lmo0096 (mannose-specific PTS system IIAB component, MptA), which has been linked to regulation of the virulence gene regulator PrfA [25]. Previously reported transcriptomic studies [7] only identified the coding gene for one of these 15 proteins (i.e., Lmo1454) as σH-dependent; lmo1454 (rpoD) was also identified as preceded by a σH consensus promoter, suggesting direct transcriptional regulation by σH. In addition, the coding gene for Lmo2487, one of these 15 proteins, is in an operon with lmo2485, which was previously reported to be positively regulated by σH, even though no upstream σH consensus promoter was identified, suggesting indirect regulation [7].

All authors read and approved the final manuscript.”
“Background The recognition of tobacco mosaic virus (TMV) since the end of nineteenth century [1] has sparked innumerable research towards its potential applications in biomedicine [2, 3] and biotemplates for novel nanomaterial syntheses [4, 5]. A TMV is composed of a single-strand RNA that is coated with 2,130 protein molecules, forming a special tubular structure with a length of 300 nm, an inner diameter of 4 nm, and an outer diameter of 18 nm [6]. The TMVs observed under a microscope can reach several tens of microns in length due to its unique feature of head-to-tail self-assembly

[7]. Practically useful properties of the TMVs include the ease of culture and broad range of thermal stability [8]. Biochemical studies have shown that the TMV mutant can function as extracellular matrix proteins, which guide the

cell adhesion and spreading [8]. It has PLX4032 order also been confirmed that stem cell differentiation can be enhanced by both native and chemically modified TMV through regulating the gene’s expression [9–11]. Moreover, TMV can be electrospun with polyvinyl alcohol (PVA) into continuous TMV/PVA composite nanofiber to form a biodegradable nonwoven fibrous mat as an extracellular matrix mimetic [12]. Very recently, Daporinad in vivo we have reported that the newly synthesized hexagonally packed TMV/Ba2+ superlattice material can be formed in aqueous solution [13, 14]. Figure 1 shows the schematic of the superlattice formation by hexagonal packing of TMVs, triggered by Ba ions, and the images observed from field emission scanning electron microscopy (FESEM) and atomic force microscopy (AFM). The sample we used for this experiment was tens of microns in length, 2 ~ 3 microns in width (from FESEM), and several hundred nanometers in height (from AFM height image).

It is known that the superlattice exhibits physical and mechanical properties that differ significantly from its constituent materials [15–20]. The study on the Parvulin viscoelastic properties of the TMV-derived nanostructured materials is still lacking despite the availability of the elastic property of the TMV and TMV-based nanotube composites [7]. The viscoelasticity of micro/nanobioarchitecture significantly affects the tissue regeneration [21] and repair [22], cell growth and aging [23], and human stem cell differentiation [24] as well as the appropriate biological functions of the membranes within a specific nanoenvironment [25]; in particular, the viscoelasticity of some viruses plays key roles in the capsid expansion for releasing nucleic acid and modifying protein cages for vaccine delivery purposes [26]. Specifically, for TMV superlattice, its nanotube structure makes it a perfect biotemplate for synthesizing nanolattices that have been confirmed to possess extraordinary mechanical features with ultralow density [27, 28].

Minimal residual tumor and longer progression-free

interval were reported to indicate improving survival outcomes BI 6727 order in most studies [5, 8, 30, 31]. On the other hand, some studies found residual tumor and progression-free interval had no impact of on prognosis in recurrent EOC underwent secondary CRS [4, 6, 7, 28, 32]. Our previous study found that CA-125 indicated asymptomatic recurrent cases will benefit from optimal secondary CRS [12]. Zang et al. emphasized the number of recurrent tumors. They stated those patients with solitary lesions, no ascites at recurrence, achieved initial optimal surgical outcomes and survival benefit more easily for secondary CRS and further confirmed it in a large population more than one thousand cases [20, 21, 33]. Berek et al. reported that recurrent tumor size had an impact on survival while Park et al. denied the relationship between the size of the recurrent tumor and survival outcomes [5, 29]. In our series, three major prognostic AZD1152-HQPA datasheet factors affected survival after secondary CRS: optimal resection after initial CRS, asymptomatic recurrent status and longer PFS duration after primary treatment. Morbidity and mortality rates during perioperative period are also important issues when secondary CRS is considered in the management of recurrent ovarian cancer. Postoperative morbidity rates reported to be ranged from 5% to 35% in different trials [5, 23, 26, 34]. In general,

secondary CRS was considered to be a safe procedure in the management of recurrent EOC [5, 35, 36]. There was no operation related deaths in our series. There are limitations to the present study. Firstly, unavoidable selection biases inherent to its retrospective design. CRS status, chemotherapy regimens and some additional salvage therapy Calpain may have reflected certain selected factors that may influence prognosis, though we eliminate the influence of consolidation or maintenance treatment by inclusion criteria. Secondly, given the long

time follow up and the heterogeneity of therapy strategies used throughout the 23 years study period, including the emergence of new regimens such as paclitaxel based chemotherapy and targeted therapy and so on, it was impossible to unify the therapy strategy. Thirdly, the absence of unified recruited standard for secondary CRS and limited sample size were factors may also cause selection bias. Last but not nest, populations underwent secondary CRS was relatively young and healthy with a good performance status, and a high likelihood of endure postoperative chemotherapy. It cannot be translated to all recurrent EOCs until further studies with broader inclusion criteria are available. Evaluating patients from China with validation set from America may help to lessen this unfavorable effect. In summary, in this study including patients from two centers with same recruited standard, we found that secondary CRS has survival benefit to selected patients.

PubMedCrossRef 14. Landete JM, Arena ME, Pardo I, Manca de Nadra MC, Ferrer S: Comparative survey of putrescine production from agmatine deamination in different bacteria.

Food Microbiol 2008, 25:882–887.PubMedCrossRef 15. Greene JD, Klaenhammer TR: Factors involved in adherence of lactobacilli to human Caco-2 cells. Appl Environ Microbiol 1994, 60:4487–4494.PubMed 16. Fernández de Palencia P, Fernández M, Mohedano ML, Ladero V, Quevedo C, Alvarez MA, López P: The role of tyramine synthesis by food-borne Enterococcus durans in the adaptation GSK1120212 ic50 to the gastrointestinal tract environment. Appl Environ Microbiol 2011, 77:699–702.PubMedCrossRef 17. Moreno-Arribas V, Torlois S, Joyeux A, Bertrand A, Lonvaud-Funel A: Isolation, properties and behaviour of tyramine-producing lactic acid bacteria from wine. J Appl Microbiol 2000, 88:584–593.PubMedCrossRef 18. Lucas PM, Landete JM, Coton M, Coton E, Lonvaud-Funel A: The tyrosine decarboxylase operon of Lactobacillus brevis IOEB 9809: characterization and conservation in tyramine-producing bacteria. FEMS Microbiol Lett 2003, 229:65–71.PubMedCrossRef 19. Wolken WA, Lucas

PA, Lonvaud-Funel A, Lolkema JS: The mechanism of the tyrosine transporter TyrP supports a proton motive decarboxylation pathway in Lactobacillus brevis. J Bacteriol 2006, 188:2198–2206.PubMedCrossRef 20. Marieb EN, Hoehn K: Human anatomy and physiology. 8 th ed edition. Benjamin Cummings Publishing Co, San Francisco; 2009. 21. Fernández de Palencia P, López P, Corbí AL, Peláez C, Requena T: Probiotic strains: survival under simulated selleck chemical gastrointestinal conditions, in vitro adhesion to Caco-2 cells and effect on cytokine secretion. Eur Food Res Technol 2008, 227:1475–1484.CrossRef 22. Fernández de Palencia P, Werning ML, Sierra-Filardi NADPH-cytochrome-c2 reductase E, Dueñas MT, Irastorza A, Corbí AL, López P: Probiotic properties of the 2-substituted (1,3)-β-D-glucan-producing bacterium Pediococcus parvulus 2.6. Appl Environ Microbiol 2009, 75:4887–4891.CrossRef 23. Garai-Ibabe G, Dueñas MT, Irastorza A, Sierra-Filardi E, Werning ML, López P, Corbí AL, Fernández de Palencia P: Naturally occurring 2-substituted (1,3)-β-D-glucan producing Lactobacillus suebicus

and Pediococcus parvulus strains with potential utility in the production of functional foods. Biores Technol 2010, 101:9254–9263.CrossRef 24. Moreno-Arribas V, Lonvaud-Funel A: Tyrosine decarboxylase activity of Lactobacillus brevis IOEB 9809 isolated from wine and Lb. brevis ATCC 367. FEMS Microbiol Lett 1999, 180:55–60.PubMedCrossRef 25. Griswold AR, Jameson-Lee M, Burne RA: Regulation and physiological significance of the agmatine deiminase system of Streptococcus mutans UA159. J Bacteriol 2006, 188:834–841.PubMedCrossRef 26. Alberto MR, Arena ME, Manca de Nadra MC: Putrescine production from agmatine by Lactobacillus hilgardii: effect of phenolic compounds. Food Control 2007, 18:898–903.CrossRef 27. Griswold AR, Chen YYM, Burne RA: Analysis of an agmatine deiminase gene cluster in Streptococcus mutans UA159.

Limnol Oceanogr Meth 2007, 5:353–362.CrossRef 26. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B: Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat

Methods 2008, 5:621–628.PubMedCrossRef 27. Taboada B, Ciria R, Martinez-Guerrero CE, Merino E: ProOpDB: prokaryotic Temsirolimus operon DataBase. Nucleic Acids Res 2012, 40:D627-D631.PubMedCentralPubMedCrossRef 28. Steglich C, Futschik ME, Lindell D, Voss B, Chisholm SW, Hess WR: The challenge of regulation in a minimal photoautotroph: Non-coding RNAs in Prochlorococcus . PLoS Genet 2008,4(8):e1000173.PubMedCentralPubMedCrossRef 29. Steglich C, Lindell D, Futschik M, Rector T, Steen R, Chisholm SW: Short RNA half-lives in the slow-growing marine cyanobacterium Prochlorococcus . Genome Biol 2010, 11:R54.PubMedCentralPubMedCrossRef DAPT molecular weight 30. Holtzendorff J, Partensky F, Mella D, Lennon J-F, Hess WR, Garczarek L: Genome streamlining results in loss of robustness of the circadian clock in the marine cyanobacterium Prochlorococcus marinus PCC 9511. J Biol Rhythms 2008, 23:187–199.PubMedCrossRef 31. Mary I, Vaulot D: Two-component systems in Prochlorococcus MED4: Genomic analysis and differential expression under stress. FEMS

Microbiol Lett 2003, 226:135–144.PubMedCrossRef 32. Memon D, Singh AK, Pakrasi HB, Wangikar PP: A global analysis of adaptive evolution of operons in cyanobacteria. Antonie Van Leeuwenhoek 2013,103(2):331–346.PubMedCrossRef 33. Klein MG, Zwart P, Bagby SC, Cai F, Chisholm SW, Heinhorst S, Cannon GC, Kerfeld CA: Identification and structural analysis of a novel carboxysome shell protein with implications for metabolite transport. J Mol Biol 2009, 392:319–333.PubMedCrossRef 34. Sorek R, Cossart P: Prokaryotic transcriptomics: a new view on regulation, physiology and pathogenicity. Nat Rev Genet many 2010, 11:9–16.PubMedCrossRef

35. Gardner PP, Daub J, Tate JG, Nawrocki EP, Kolbe DL, Lindgreen S, Wilkinson AC, Finn RD, Griffiths-Jones S, Eddy SR, Bateman A: Rfam: updates to the RNA families database. Nucleic Acids Res 2009, 37:D136-D140.PubMedCentralPubMedCrossRef 36. Tagwerker C, Dupont CL, Karas BJ, Ma L, Chuang RY, Benders GA, Ramon A, Novotny M, Montague MG, Venepally P, et al.: Sequence analysis of a complete 1.66 Mb Prochlorococcus marinus MED4 genome cloned in yeast. Nucleic Acids Res 2012,40(20):10375–10383.PubMedCentralPubMedCrossRef 37. Naville M, Ghuillot-Gaudeffroy A, Marchais A, Gautheret D: ARNold: a web tool for the prediction of Rho-independent transcription terminators. RNA Biol 2011, 8:11–13.PubMedCrossRef 38. Waldbauer JR, Rodrigue S, Coleman ML, Chisholm SW: Transcriptome and proteome dynamics of a light–dark synchronized bacterial cell cycle. PLoS One 2012, 7:e43432.PubMedCentralPubMedCrossRef 39. Zhang R, Lin Y: DEG 5.0, a database of essential genes in both prokaryotes and eukaryotes.

Wide-gap semiconductor ZnO was also investigated, since the band gap and the energetic position of the valence band maximum and conduction band minimum of ZnO are very close to those of TiO2[9]. Most of these composite materials were synthesized through chemical techniques, although physical deposition, such as sputtering, is also useful. In addition, one-step synthesis of a composite thin film is favorable for low-cost production of solar cells. Package synthesis requires a specific material design for each deposition technique, for example, radio frequency (RF) sputtering [10, 11] and hot-wall deposition [12]. The present study proposes a new composite

thin film with InSb-added TiO2 produced by RF sputtering. InSb nanocrystals may exhibit relatively high absorption efficiency due to a direct click here band structure with 0.17eV [13] and an exciton Bohr radius of 65.5 nm [14]. According to the material design, based on differences in the heat of formation [10, 11], InSb nanocrystals are thermodynamically stable in an TiO2, since Ti is oxidized more than InSb because the free energy of oxidation in InSbO4, which is a typical oxide of InSb, exceeds that of the TiO2[15, 16]. In addition, nanocrystalline InSb dispersed in the oxide matrix may exhibit quantum size effects, due to the wide band-gap of 3.2 eV BI2536 in TiO2 with anatase structure [17]. However, it is difficult

to forecast how the composite will be formed in the one-step synthesis, since the compound semiconductor, InSb, may have decomposed during the preparation process. In the current study, the composition of InSb-added TiO2 nanocomposite film is varied widely to find a composite with Megestrol Acetate vis-NIR

absorption due to the presence of InSb nanocrystals embedded in the wide-gap oxide matrix. Methods An InSb-added TiO2 nanocomposite film was prepared by RF sputtering from a composite target. Specifically, 5 × 5 mm2 InSb chips, which were cleaved from a 2-in diameter InSb (100) wafer, were set on a 4-in diameter ceramic TiO2 target. The chamber was first evacuated to a vacuum of 1.5 × 10−7 Torr. InSb-added TiO2 nanocomposite films were deposited on a Corning #7059 glass substrate (Norcross, GA, USA) cooled by water. The distance between the target and the substrate was kept constant at 73 mm. The total gas pressure of argon or argon with diluted oxygen was fixed at 2.0 × 10−3 Torr. RF power and deposition time were kept constant at 200 W and 60 min, and no RF bias was applied to the substrate. The InSb-added TiO2 nanocomposite films thus deposited were successively annealed at temperatures from 623 to 923 K in 50 K steps for 60 min in a vacuum to crystallize both InSb and TiO2. The film was structurally characterized using X-ray diffraction (XRD, Rigaku RAD-X, Rigaku Corporation, Tokyo, Japan).